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LETTER TO THE EDITOR
APROPOS “EVALUATION OF DENGUE NS1 ANTIGEN DETECTION FOR DIAGNOSIS IN PUBLIC 
HEALTH LABORATORIES, SÃO PAULO STATE, 2009”
Delhi, December 26, 2011
Dear Sir
We compliment investigators in Public Health laboratories in the São Paulo State, for their meticulous evaluation of the importance of dengue 
NS1 antigen detection for monitoring the introduction and the spread of dengue virus (DENV) serotypes3. Apart from rapid detection of DENV NS1 
antigen, simultaneous detection of DENV-IgM, -IgG and enumeration of circulating platelets would be useful for the diagnosis of several additional 
cases and for the prompt detection of those who have had severe thrombocytopenia. 
One-tier testing would be beneficial in patients with a primary or secondary DENV with severe thrombocytopenia. They could be offered platelet 
infusions straightaway. Testing for DENV NS1, IgM and IgG rather than IgM alone was advantageous in the 175 suspected cases of DENV during 
the 2010 outbreak of DENV in the Indian capital, New Delhi. There were 86 NS1-positive cases and 89 NS1-negatives. NS1 positives included 57 
that were negative for IgM and four which were only positive for IgG. Of these 61 patents there were 57 with a primary infection and secondary 
infection which would otherwise have been labeled as negative1. Furthermore, there was a great variation in platelet counts during different stages 
of the disease evolution. Platelet counts were lower in those positive for NS1 (and IgM and/or IgG positives) than in those who were NS1 negative2.
Surely, concurrent search for DENV NS1, IgM, IgG and platelet enumeration would be useful in Public Health laboratories in the São Paulo 
State3. Moreover, the immunochromatographic assay for DENV NS1, IgM and IgG would emerge as the ideal option in the majority of non-academic, 
non-research health care centers. Facilities for sophisticated tests like ELISA, cell culture or molecular studies are not available in many laboratories, 
not only in remote locations, but also in big cities in developing countries4. 
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